31-45 of 280
Treating Osteoporosis in Older Adults: The Limitations of BMD Measurements
On the Frontlines of OsteoporosisTreating Osteoporosis in Older Adults: The Limitations of BMD Measurements
Cathleen Colón-Emeric, MD
Treating Osteoporosis in Elderly Patients with High Fall Risk
On the Frontlines of OsteoporosisTreating Osteoporosis in Elderly Patients with High Fall Risk
Cathleen Colón-Emeric, MD
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
On the Frontlines of Multiple SclerosisAging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Charles Turck, PharmD, BCPS, BCCCP
Yinan Zhang, MD
Sarah A. Morrow, MD, MS, FRCPC, FAAN
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
On the Frontlines of Multiple SclerosisManaging MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Charles Turck, PharmD, BCPS, BCCCP
Kimberly DiMauro, DO
Carol Swetlik, MD
Osteoporosis in Postmenopausal Women: Sequencing Strategies and Challenges
On the Frontlines of OsteoporosisOsteoporosis in Postmenopausal Women: Sequencing Strategies and Challenges
Felicia Cosman, MD
Optimizing Anabolic and Antiresorptive Treatment Transitions for Osteoporosis
On the Frontlines of OsteoporosisOptimizing Anabolic and Antiresorptive Treatment Transitions for Osteoporosis
Felicia Cosman, MD
- advertisement
Preventing Osteoporosis with Hormone Therapy: How to Select Appropriate Patients
On the Frontlines of OsteoporosisPreventing Osteoporosis with Hormone Therapy: How to Select Appropriate Patients
Risa Kagan, MD, FACOG, CCD, NCMP
Menopausal Hormone Therapy for Bone Health: Balancing Benefits and Risks
On the Frontlines of OsteoporosisMenopausal Hormone Therapy for Bone Health: Balancing Benefits and Risks
Risa Kagan, MD, FACOG, CCD, NCMP
Menopause and Bone Health: Modern Approaches for Healthcare Providers
Boning Up on OsteoporosisMenopause and Bone Health: Modern Approaches for Healthcare Providers
Claire Gill
Andrea Singer, MD, FACP, CCD
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
NeuroFrontiersBeyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
Thomas Karikari, PhD
Preventing Alzheimer’s Disease Through Lifestyle Interventions
NeuroFrontiersPreventing Alzheimer’s Disease Through Lifestyle Interventions
Michele Longo, MD
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
NeuroFrontiersAmyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
Michele Longo, MD
- advertisement
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
NeuroFrontiersDebunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Clifford Jack Jr., MD
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
NeuroFrontiersReviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Clifford Jack Jr., MD
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
NeuroFrontiersBeyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Ashley Baker, MSN, PMHNP
Suzanne E. Schindler, MD, PhD
